RF
67
-2
AVY
54
-4
CTSH
60
3
SYK
68
4
AES
41
-2
AMGN
31
-16
LB
60
4
SIG
50
-5
PM
66
4
NWSA
63
-4
SLG
64
-2
OKE
78
3
CB
55
2
SWKS
51
-2
INTU
56
3
CVX
46
8
VNO
68
3
CVS
52
-6
MRK
35
2
MSFT
57
6
RF
67
-2
AVY
54
-4
CTSH
60
3
SYK
68
4
AES
41
-2
AMGN
31
-16
LB
60
4
SIG
50
-5
PM
66
4
NWSA
63
-4
SLG
64
-2
OKE
78
3
CB
55
2
SWKS
51
-2
INTU
56
3
CVX
46
8
VNO
68
3
CVS
52
-6
MRK
35
2
MSFT
57
6
Financhill
Back

ProShares UltraPro Short S&P500 Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
18

SPXU
ProShares UltraPro Short S&P500

Last Price:
21.66
Seasonality Move:
-15.35%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.48
Seasonality Move:
14.88%
Sell
18
ProShares UltraPro Short S&P500 (SPXU) is a Sell

Is ProShares UltraPro Short S&P500 a Buy, Sell or Hold?

  • The current ProShares UltraPro Short S&P500 [SPXU] share price is $21.43. The Score for SPXU is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • SPXU is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPXU Stock Price Chart

What is ProShares UltraPro Short S&P500's stock price today?

  • The ProShares UltraPro Short S&P500 share price today is $21.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPXU is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPXU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.57 Sell
Relative Strength Index (14 RSI): 34.99 Sell
Chaikin Money Flow: -6148819 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.77 - 24.05) Sell
Bollinger Bands (100): (23.11 - 28.63) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

SPXU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.27 Sell
20-day SMA: 22.7 Sell
50-day SMA: 23.61 Sell
200-day SMA: 29.6 Sell
8-day EMA: 22.04 Sell
20-day EMA: 22.54 Sell
50-day EMA: 23.77 Sell
200-day EMA: 30.84 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares UltraPro Short S&P500 Earnings Growth & SPXU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares UltraPro Short S&P500 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):